Skip to content
Trial Eligibility
Menu

Multiple Sclerosis Clinical Trials near St Louis, MO

13 studies for Multiple Sclerosis are recruiting at 17 sites within 50 miles of St Louis, Missouri, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near St Louis.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Multiple Sclerosis studies enrolling near St Louis

Showing 13 studies, nearest first.
  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Siteman Cancer Center at Christian Hospital (St Louis, MO); Siteman Cancer Center-South County (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  2. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    NCT04047628

    • Phase 3
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  3. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    NCT05877963

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: TG Therapeutics Investigational Trial Site (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. Smoldering Inflammation in MS

    NCT06591429

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Barnes Jewish Center for Clinical Imaging Research (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

    NCT06735248

    • Phase 2
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Washington University School of Medicine Neurology Clinical Unit (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

    NCT06782490

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Washington University School of Medicine (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    NCT06846281

    • Phase 3
    • Ages 40 to 70 years
    • Sex: All

    Nearest site: WA Uni School Of Med (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    NCT07067463

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Washington University School of Medicine (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

    NCT07115017

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Washington University in St. Louis (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    NCT07224373

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Research Site (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    NCT07299019

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Washington University School of Medicine (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

    NCT07477639

    • Phase 1/2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Washington University, St. Louis (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

    NCT07758270

    • Observational
    • Ages 40 to 70 years
    • Sex: All

    Nearest site: Washington University School of Medicine in St. Louis (St Louis, MO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Multiple Sclerosis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.